Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves expanded access for retinitis pigmentosa gene therapy ➤ Generic steroid receives FDA approval for inflammation ➤ AI-powered smart glasses provide visual help to patients with AMD ➤ ASCRS news and events
➤ FDA 510(k) clearance granted to cataract surgery system ➤ Laser for POAG receives CE Mark ➤ Collaboration to develop dry eye treatment ➤ First patients enrolled in Phase 3 wet AMD trial ➤ New open-access textbook on lens power calculations ➤ ASCRS news and events
➤ Study: protein patterns in tears predict postop pain ➤ Tentative approval for generic glaucoma drug ➤ Nanodrug recovers optic nerve in glaucoma animal model ➤ Acquisition news ➤ ASCRS news and events
ASCRS EyeWorld Weekly: View the current issue ➤ Claes Dohlman, MD, PhD, dies at 101 years old ➤ Trial to evaluate neuropathic corneal pain drug ➤ FDA clears new OCT technology ➤ Study: supplements slow progression of late-stage dry AMD ➤ Young eye surgeon scholarship opportunity ➤ Acquisition news ➤ ASCRS news and events
➤ FDA grants De Novo classification to ocular pressure adjusting pump ➤ Inaugural ‘State of Dry Eye’ survey ➤ Study: potentially higher risk for blinding ocular condition with semaglutide use ➤ Wet AMD treatment implant reintroduced ➤ Acquisition news ➤ ASCRS news and events
➤ Prospective trial reveals impact of home OCT in wet AMD management ➤ Devices receive FDA 510(k) clearance ➤ Review date set for BLA for treatment of macular telangiectasia type 2 ➤ FDA grants IND to gene therapy for patients with geographic atrophy ➤ Acquisition news ➤ ASCRS news and events
➤ Allogenic cell therapy receives FDA designations ➤ Robot delivers new treatment for wet AMD ➤ Health-related quality of life measure proposed for MIGS ➤ Company meets with FDA for pediatric myopia drug candidate ➤ ASCRS news and events
➤ Topline results from trial for biologic eye drop for dry eye ➤ First patient dosed in Phase 3 trial evaluating oral non-opioid sedation ➤ First patient dosed in retinitis pigmentosa gene therapy trial ➤ Clinical program for IOP-lowering drug discontinued ➤ ASCRS news and events
➤ 52-week Phase 3 data published for cyclosporine, 0.1% ➤ First patient enrolled in Phase 3 trial assessing new treatment for MGD ➤ Geographic atrophy treatment trial advances to highest dose ➤ New dataset added to support various areas of research and development ➤ ASCRS news and events
➤ Twelve-month results for Phase 2 trial evaluating heat-therapy system for MGD ➤ Topline results from targeted photobiomodulation for treatment of progressive myopia ➤ Enrollment complete in Phase 3 trials to evaluate new wet AMD therapy ➤ ‘Low tech’ way to prioritize cataract surgery ➤ ASCRS news and events